Apolipoprotein F is predominantly associated with low density lipoprotein and functions as an inhibitory regulator of cholesteryl ester transfer protein (CETP).
Apolipoprotein F, a minor apolipoprotein in human plasma, was isolated and partially characterized by Olofsson et al.
(1978).
By PCR of a human hepatoma cell line cDNA library using primers based on the N-terminal sequence of purified APOF, Day et al.
(1994) cloned full-length APOF.
The deduced 308aa proprotein has a 22aa N-terminal signal peptide, and its C-terminal half contains the mature APOF peptide, which is released by proteolytic processing.
The mature 162aa hydrophobic APOF peptide has a calculated molecular mass of 17.4kD and contains sites for N- and O-glycosylation.
Applications:Suitable for use in ELISA, Western Blot, Immunohistochemistry, Immunocytochemistry.
Other applications not tested.
Recommended Dilution:ELISA: 1:100-1:5000 Western Blot: 1:50-400Immunohistochemistry (frozen): 1:50-500Immunohistochemistry (paraffin): 1:10-100Immunocytochemistry: 1:50-500Optimal dilutions to be determined by the researcher.